Hormone replacement therapy is associated with gastro-oesophageal reflux disease: A retrospective cohort study

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Close, Helen ^a   Mason, James M ^a   Wilson, Douglas ^a   Hungin, A Pali S ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Gastro oesophageal reflux disease; Hormone replacement therapy; Menopause

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; GESTAGEN; HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TIBOLONE;

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; GASTROESOPHAGEAL REFLUX; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; RETROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM;

ADULT; AGED; COHORT STUDIES; ESTROGENS; FEMALE; GASTROESOPHAGEAL REFLUX; GREAT BRITAIN; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; PROGESTINS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861464012     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-56     Document Type: Article

References (33)

1. Klauser AG, Schindlbeck N, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990, 335(8683):205-208. 10.1016/0140-6736(90)90287-F, 1967675.
2. Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991, 6:73-81.
3. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of Gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448-1456. 10.1016/S0016-5085(97)70025-8, 9136821.
4. He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, Yin P, Kang X, Fang J, Hao Y, Li Q, Dent J, Sung J, Zou D, Wallander M, Johansson S, Liu W, Li Z. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. Gastroenterology 2010, 10:94. 2933714, 20707933.
5. Mason J, Hungin APS. Review article: GORD - the health economic implications. Aliment Pharmacol Ther 2005, 22(Suppl. 1):20-31.
6. Younes Z, Johnson DA. Diagnostic evaluation in gastroesophageal reflux disease. Gastroenterol Clin N Am 1999, 28:809-830.
7. Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 2000, 95:1881-1887. 10.1111/j.1572-0241.2000.02235.x, 10950030.
8. Solaymani-Doraran M, Logan RF, West J, et al. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study. Am J Gastroenterol 2005, 100:2616-2621. 10.1111/j.1572-0241.2005.00340.x, 16393209.
9. Cameron AJ, Lagergren J, Henriksson C, et al. Gastrooeophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002, 122:55-59. 10.1053/gast.2002.30301, 11781280.
10. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004, 20:751-760. 10.1111/j.1365-2036.2004.02169.x, 15379835.
11. Nilsson M, Johnsen R, Ye W, et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004, 53:1730-1735. 10.1136/gut.2004.043265, 1774312, 15542505.
12. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. Jama 2003, 290:66-72. 10.1001/jama.290.1.66, 12837713.
13. Smout AJPM. Gastro-oesophageal reflux disease: Pathogenesis and Diagnosis. Evolving concepts in Gastrointestinal Motility 1996, 46-63. Blackwell Science, Oxford, England, Champion MC, Orr WC.
14. Van Thiel DH, Gavaler JS, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 1976, 71:232-234.
15. Singh S, Poulsom R, Longcroft JM, et al. Is cyclical bowel habit mediated by female sex hormones?. Eur J Gastroenterol Hepatol 1994, 6:925-930.
16. Bruce L, Faiz B. Progesterone effects on three regional gastrointestinal tissues. Life Sci 1979, 25:729-734. 10.1016/0024-3205(79)90515-0, 491852.
17. Turnbull GK, Thompson DG, Day S, et al. Relationship between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut 1989, 30:30-34. 10.1136/gut.30.1.30, 1378226, 2920923.
18. Van Thiel DH, Wald A. Evidence refuting a role for increased abdominal pressure in the pathogenesis of the heartburn associated with pregnancy. Am J Obstet Gynaecol 1981, 140:420-422.3.
19. Menon S, Trudgill N. Is hormone replacement therapy associated with reflux oesophagitis, Barrett's oesophagus and oesophageal cancer?. Gut 2010, 59(Suppl III):A117.
20. Nordenstedt H, Zheng Z, Cameron AJ, et al. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology 2008, 134(4):921-928. 10.1053/j.gastro.2008.01.009, 2359826, 18294635.
21. Zheng Z, Margolis KL, Liu S, et al. Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology 2008, 135(1):72-81. 10.1053/j.gastro.2008.03.039, 2725519, 18502208.
22. Jacobson BC, Moy B, Colditz GA, et al. Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med 2008, 168(16):1798-1804. 10.1001/archinte.168.16.1798, 2761884, 18779468.
23. Alvarez-Sánchez A, Rey E, Achem SR, et al. Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux?. Am J Gastroenterol 1999, 6:1468-1471.
24. The General Practice Research Database , , www.gprd.com.
25. El-Serag-Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther 2009, 29:470-480. 10.1111/j.1365-2036.2008.03901.x, 19035977.
26. Communities and Local Government. Communities and neighbourhoods, Indices of Deprivation 2008: PCT Summaries ID 2008, , .
27. Zervou S, Klentzeris LD, Old RW. Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia. Mol Hum Reprod 1999, 5:1048-1054. 10.1093/molehr/5.11.1048, 10541567.
28. Nuedling S, Kahlert S, Loebbert K, et al. 17-Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 1999, 43:666-674. 10.1016/S0008-6363(99)00093-0, 10690338.
29. Cummings SR, Etttinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. NEJM 2008, 359:697-708. 10.1056/NEJMoa0800743, 18703472.
30. Bakken K, Eggen AE, Lund E. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstetricia et Gynecologica Scandinavica 2004, 83(9):850-856.
31. Hall P, Ploner A, Bjohle J, Hunag F, Lin C, Liu E, Miller L, Nordgren H, Pawitan Y, Shaw P, Skoog L, Smeds J, Wedren S, Ohd J, Bergh J. Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study. BMC Medicine 2006, 4:16. 10.1186/1741-7015-4-16, 1555602, 16813654.
32. Talley NJ, Weaver A, Zinsmeister AR, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992, 136:165-177.
33. Studd J, et al. HRT and long-term compliance: The efficacy and safety of Menorest. Int J Gynecol Obstet 1996, 52(Suppl 1):S21-S25.